Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovary Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04377087
What this trial is testing

Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Sarah E Taylor 3
Early research (Phase 1)Ended earlyNCT06466187
What this trial is testing

SGN-MesoC2 in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more
Seagen, a wholly owned subsidiary of Pfizer 19
Testing effectiveness (Phase 2)UnknownNCT04072263
What this trial is testing

Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer Recurrent
Leiden University Medical Center 12
Not applicableEnded earlyNCT01744821
What this trial is testing

Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Northwestern University 7
Testing effectiveness (Phase 2)Study completedNCT00194714
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab

Who this might be right for
HER2/Neu PositiveHLA-A2 Positive Cells PresentStage IV Breast Cancer+1 more
University of Washington 22
Not applicableStudy completedNCT06201221
What this trial is testing

Single-port Laparoscopy in Children and Adolescents

Who this might be right for
Benign Ovarian Tumors
Fujian Maternity and Child Health Hospital 300
Testing effectiveness (Phase 2)UnknownNCT06541314
What this trial is testing

Fluzoparib Neoadjuvant Therapy for Ovarian Cancer

Who this might be right for
Ovarian Cancer
Qilu Hospital of Shandong University 48
Not applicableActive Not RecruitingNCT00579163
What this trial is testing

Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsColonic Neoplasms+4 more
Memorial Sloan Kettering Cancer Center 992
Not applicableLooking for participantsNCT06545721
What this trial is testing

Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Peking Union Medical College Hospital 425
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Testing effectiveness (Phase 2)Study completedNCT00002671
What this trial is testing

Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
NYU Langone Health
Not applicableStudy completedNCT06145295
What this trial is testing

The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life

Who this might be right for
Ovarian Cancer
Shanghai Jiao Tong University School of Medicine 68
Testing effectiveness (Phase 2)UnknownNCT01100372
What this trial is testing

Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Medical University Innsbruck 154
Early research (Phase 1)Study completedNCT00315861
What this trial is testing

Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer+1 more
SCRI Development Innovations, LLC 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362
What this trial is testing

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Who this might be right for
Urinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more
BicycleTx Limited 329
Large-scale testing (Phase 3)Study completedNCT01081639
What this trial is testing

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

Who this might be right for
InfertilityOvulation Induction
Merck KGaA, Darmstadt, Germany 34
Early research (Phase 1)Study completedNCT00003588
What this trial is testing

Gene Therapy in Treating Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Cancer Institute (NCI) 30
Early research (Phase 1)Looking for participantsNCT06646627
What this trial is testing

Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors

Who this might be right for
Ovarian Cancer
Stanford University 48
Large-scale testing (Phase 3)UnknownNCT04885270
What this trial is testing

Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer

Who this might be right for
Epithelial Carcinoma, OvarianNeoadjuvant Chemotherapy
West China Second University Hospital 50
Early research (Phase 1)Study completedNCT01314105
What this trial is testing

BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal Neoplasms
Boehringer Ingelheim 19
Next Page